Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary

P Raskin, AH Cincotta - Expert review of endocrinology & …, 2016 - Taylor & Francis
An extended series of studies indicate that endogenous phase shifts in circadian neuronal
input signaling to the biological clock system centered within the hypothalamic …

Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary.

P Raskin, AH Cincotta - Expert Review of Endocrinology & …, 2016 - europepmc.org
An extended series of studies indicate that endogenous phase shifts in circadian neuronal
input signaling to the biological clock system centered within the hypothalamic …

Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: Developmental basis and therapeutic profile summary

P Raskin, AH Cincotta - Expert Review …, 2016 - utsouthwestern.elsevierpure.com
An extended series of studies indicate that endogenous phase shifts in circadian neuronal
input signaling to the biological clock system centered within the hypothalamic …

Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary

P Raskin, AH Cincotta - Expert review of endocrinology & …, 2016 - pubmed.ncbi.nlm.nih.gov
An extended series of studies indicate that endogenous phase shifts in circadian neuronal
input signaling to the biological clock system centered within the hypothalamic …